Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 156,400 | 71,000 | 79,000 | 111,700 | 87,800 |
| Receivables | 121,300 | 196,300 | 233,500 | 191,000 | 216,500 |
| Inventories | 322,700 | 317,500 | 333,400 | 328,900 | 354,100 |
| Other current assets | 0 | 33,700 | 0 | 0 | 0 |
| TOTAL | $661,400 | $654,500 | $682,400 | $679,500 | $720,800 |
| Non-Current Assets | |||||
| PPE Net | 278,100 | 306,200 | 379,400 | 382,800 | 395,400 |
| Intangibles | 517,800 | 534,100 | 550,400 | 566,600 | 582,800 |
| Other Non-Current Assets | 20,500 | 18,700 | 191,400 | 194,300 | 194,100 |
| TOTAL | $816,400 | $859,000 | $1,121,200 | $1,143,700 | $1,172,300 |
| Total Assets | $1,477,800 | $1,513,500 | $1,803,600 | $1,823,200 | $1,893,100 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 800 | 415,200 | 459,200 | 413,700 | 413,600 |
| Accounts payable and accrued liabilities | 82,100 | 95,900 | 100,200 | 112,200 | 112,700 |
| Accrued Expenses | 79,400 | 83,900 | 56,300 | 92,700 | 99,500 |
| Other current liabilities | 67,600 | 24,700 | 14,500 | 32,700 | 38,200 |
| TOTAL | $229,900 | $619,700 | $630,200 | $651,300 | $664,000 |
| Non-Current Liabilities | |||||
| Long Term Debt | 661,800 | 447,000 | 446,700 | 446,500 | 448,200 |
| Other Non-Current Liabilities | 35,800 | 25,700 | 28,000 | 28,900 | 31,300 |
| TOTAL | $739,500 | $507,500 | $509,500 | $522,600 | $531,900 |
| Total Liabilities | $969,400 | $1,127,200 | $1,139,700 | $1,173,900 | $1,195,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,184 | 52,907 | 52,402 | 52,203 | 51,884 |
| Common Shares | 100 | 100 | 100 | 100 | 100 |
| Retained earnings | -181,100 | -295,900 | -12,800 | -21,800 | 27,700 |
| Other shareholders' equity | -7,000 | -5,200 | -5,200 | -5,400 | -2,300 |
| TOTAL | $508,400 | $386,300 | $663,900 | $649,300 | $697,200 |
| Total Liabilities And Equity | $1,477,800 | $1,513,500 | $1,803,600 | $1,823,200 | $1,893,100 |